INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,781,019 | -25.3% | 4,578,455 | -14.3% | 0.00% | 0.0% |
| Q2 2023 | $2,384,423 | +35308.7% | 5,340,253 | +23.7% | 0.00% | -75.0% |
| Q4 2022 | $6,734 | -99.8% | 4,316,357 | +105.7% | 0.00% | +100.0% |
| Q3 2022 | $3,619,000 | +205.7% | 2,098,235 | +1169.2% | 0.00% | +100.0% |
| Q3 2021 | $1,184,000 | +27.7% | 165,316 | +65.3% | 0.00% | 0.0% |
| Q2 2021 | $927,000 | -79.0% | 100,000 | -78.9% | 0.00% | -66.7% |
| Q1 2021 | $4,408,000 | -12.5% | 475,002 | -16.5% | 0.00% | 0.0% |
| Q4 2020 | $5,037,000 | +756.6% | 569,116 | +1021.9% | 0.00% | +200.0% |
| Q3 2020 | $588,000 | -86.7% | 50,729 | -69.2% | 0.00% | -83.3% |
| Q2 2020 | $4,435,000 | -64.8% | 164,541 | -90.3% | 0.01% | -78.6% |
| Q1 2020 | $12,586,000 | +22783.6% | 1,691,661 | +10001.9% | 0.03% | – |
| Q4 2019 | $55,000 | -60.7% | 16,746 | -52.1% | 0.00% | – |
| Q4 2018 | $140,000 | -61.6% | 34,971 | -46.7% | 0.00% | – |
| Q3 2018 | $365,000 | -28.3% | 65,643 | -49.4% | 0.00% | -100.0% |
| Q2 2018 | $509,000 | +125.2% | 129,750 | +170.3% | 0.00% | – |
| Q1 2018 | $226,000 | +4.6% | 48,001 | -8.4% | 0.00% | – |
| Q4 2017 | $216,000 | -97.1% | 52,381 | -95.6% | 0.00% | -100.0% |
| Q3 2017 | $7,504,000 | +13.5% | 1,183,557 | +40.4% | 0.01% | -8.3% |
| Q2 2017 | $6,611,000 | +2433.0% | 843,260 | +2035.4% | 0.01% | – |
| Q1 2017 | $261,000 | -81.1% | 39,489 | -80.2% | 0.00% | -100.0% |
| Q4 2016 | $1,383,000 | +963.8% | 199,212 | +1311.8% | 0.00% | – |
| Q2 2016 | $130,000 | -84.3% | 14,110 | -85.1% | 0.00% | -100.0% |
| Q1 2016 | $826,000 | -82.4% | 94,799 | -86.4% | 0.00% | -80.0% |
| Q4 2015 | $4,687,000 | +134.5% | 697,543 | +101.7% | 0.01% | +150.0% |
| Q3 2015 | $1,999,000 | +89.3% | 345,862 | +167.4% | 0.00% | +100.0% |
| Q2 2015 | $1,056,000 | +315.7% | 129,355 | +314.9% | 0.00% | – |
| Q1 2015 | $254,000 | -49.4% | 31,181 | -43.0% | 0.00% | -100.0% |
| Q4 2014 | $502,000 | -93.5% | 54,658 | -92.3% | 0.00% | -95.2% |
| Q2 2014 | $7,700,000 | – | 712,228 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |